HCA Healthcare, Inc. (NYSE:HCA) Q1 2021 Earnings Conference Call April 22, 2021 10:00 AM ET Company Participants Mark Kimbrough - VP, IR Sam Hazen - CEO Bill Rutherford - CFO Conference Call Participants Kevin Fischbeck - Bank of America Frank Morgan - RBC Capital Markets A.J. Rice - Credit Suisse Pito Chickering - Deutsche Bank Ralph Giacobbe - Citi Lance Wilkes - Bernstein Scott Fidel - Stephens Brian Tanquilut - Jefferies Justin Lake - Wolfe Research Josh Raskin - Nephron Research John Ransom - Raymond J ...

Table of Contents Index to Financial Statements UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 1-11239 HCA Healthcare, Inc. (Exact Name of Registrant as Specified in its Charter) Delaw ...

HCA Healthcare, Inc. (NYSE:HCA) Q4 2020 Earnings Conference Call February 2, 2021 12:00 PM ET Company Participants Mark Kimbrough - VP, IR Sam Hazen - CEO Bill Rutherford - CFO Conference Call Participants Kevin Fischbeck - Bank of America Gary Taylor - JPMorgan Frank Morgan - RBC Capital Markets A.J. Rice - Credit Suisse Joshua Raskin - Nephron Research Pito Chickering - Deutsche Bank Scott Fidel - Stephens Ralph Giacobbe - Citi Bank Justin Lake - Wolfe Research Whit Mayo - UBS Lance Wilkes - Bernstein Bri ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-11239 HCA Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 27-3865930 (State or other jurisdic ...

HCA Healthcare, Inc. (NYSE:HCA) Q3 2020 Results Conference Call October 26, 2020 10:00 AM ET Company Participants Mark Kimbrough - VP, IR Sam Hazen - CEO Bill Rutherford - CFO Dr. Jon Perlin - CMO Conference Call Participants Whit Mayo - UBS Pito Chickering - Deutsche Bank Gary Taylor - JP Morgan A.J. Rice - Credit Suisse Ralph Giacobbe - Citi Justin Lake - Wolfe Research Josh Raskin - Nephron Research Frank Morgan - RBC Capital Markets Brian Tanquilut - Jefferies Kevin Fischbeck - Bank of America Securitie ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 1-11239 HCA Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 27-3865930 (State or o ...

HCA Healthcare, Inc. (NYSE:HCA) Q2 2020 Earnings Conference Call July 22, 2020 10:00 AM ET Company Participants Mark Kimbrough - Vice President, Investor Relations Sam Hazen - Chief Executive Officer Bill Rutherford - Chief Financial Officer and Executive Vice President Conference Call Participants Justin Lake - Wolf Research Gary Taylor - JPMorgan A.J. Rice - Credit Suisse Pito Chickering - Deutsche Bank AG Matthew Gillmor - Robert W. Baird Whit Mayo - UBS Steven Valiquette - Barclays Kevin Fischbeck - Ban ...

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2020 Or For the transition period from to Commission file number 1-11239 HCA Healthcare, Inc. (Exact name of registrant as specified in its charter) Delaware 27-3865930 (State or ...

HCA Healthcare, Inc. (NYSE:HCA) Q1 2020 Earnings Conference Call April 21, 2020 10:00 AM ET Company Participants Mark Kimbrough - Vice President of Investor Relations Sam Hazen - CEO Bill Rutherford - CFO Dr. Jon Perlin - Chief Medical Officer Conference Call Participants Sarah James - Piper Sandler Joshua Raskin - Nephron Research Ralph Giacobbe - Citi Scott Fidel - Stephens Kevin Fischbeck - Bank of America Frank Morgan - RBC Capital Markets Whit Mayo - UBS A.J. Rice - Credit Suisse Brian Tanquilut - Jeff ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2019 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 1-11239 HCA Healthcare, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 27-3865930 (State or Other ...